Please email us at [email protected] with our item No, NDC#, UPC# or the product link if you have any quetions. We are located in Oceanside, California. Search over 110,000 items by Name, Item No., NDC, UPC (without dashes) or by Mfg.Name. Please note, Prescription items can only be ordered by a Drug Manufacturer, Wholesaler, Hospital, Governmental Medical Facility, VA, Pharmacy, Physician, Physician Assistant, Nurse Practitioner, Dentist, Podiatrist, Optometrist, Veterinarian, Naturopath, Licensed Lab, Physical Therapist & Pharmacist in their scope of practice. No order will ship, unless you you have provided us the Medical License (and DEA Lic. in case of controlled drug) and we had verified that. Rx items can only be shipped to AZ, AR, CA, CT, DE, FL, GA, GU, HI, IL, KS, KY, LA, ME, MA, MI, NJ, NY, PA, PR, TX, TN, VA, WA, WI and WV. If you are an International Physician or Pharmacist, please contact us before ordering.


Menu

Rx Item-Emflaza Deflazacort 36mg 30 Tab By Marathon Pharma

Emflaza Deflazacort 36mg 30 Tab By Marathon PharmaItem No.:Rx42998-504-03  NDC No. 42998-0504-03 42998-504-03 42998050403 4299850403  UPC/GTIN No.. 3-42998-50403-1 342998-504031 342998504031  MPN 5040Emflaza Deflazacort 30mg 30 Tab By Marathon PharmaItem No.:Rx42998-503-03  NDC No. 42998-0503-03 42998-503-03 429985033 4299850303  UPC/GTIN No.. 3-42998-50303-4 342998-503034 342998503034  MPN 850303Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.Emflaza Deflazacort 6mg 100 Tab By Marathon Pharma Item No.:Rx52856-501-01 52856-501-01 NDC No.52856-501-01, 52856-502-03, 52856-503-03, 52856-504-03 UPC No.:367457190151 NDC No. 67457-0190-15 UPC/GTIWant to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.comVisit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.Emflaza Deflazacort 36mg 30 Tab By Marathon PharmaItem No.:Rx42998-504-03  NDC No. 42998-0504-03 42998-504-03 42998050403 4299850403  UPC/GTIN No.. 3-42998-50403-1 342998-504031 342998504031  MPN 5040Emflaza Deflazacort 30mg 30 Tab By Marathon PharmaItem No.:Rx42998-503-03  NDC No. 42998-0503-03 42998-503-03 429985033 4299850303  UPC/GTIN No.. 3-42998-50303-4 342998-503034 342998503034  MPN 850303Emflaza Deflazacort 18mg 30 Tab By Marathon PharmaItem No.:Rx42998-502-03  NDC No42998-0502-03 42998-502-03 42998050203 4299850203  UPC/GTIN No.. 3-42998-50203-7 342998-502037 3-42998-50203-7 MPN 8502

Rx Item-Emflaza Deflazacort 36mg 30 Tab By Marathon Pharma

$0.00

Emflaza Deflazacort 36mg 30 Tab By Marathon PharmaItem No.:Rx42998-504-03 NDC No. 42998-0504-03 42998-504-03 42998050403 4299850403 UPC/GTIN No.. 3-42998-50403-1 342998-504031 342998504031 MPN 504031 Only Lic.-Physician, Pharmacy, Dentist, Drug Mfg, Dist., Gov, Hospital, Lic.Lab, Naturalist, Naturopath, Np, Optometrist, Pharmacist, Pa, Physical Therapist, Podiatrist, Researchco., Uni., Va, Vet & Wholesalers In Scope Of Practice Can Orde

Have a question?

  Out of stock, please email us with the item number or product link at [email protected] for the quantity available, current pricing and eligibility to purchase.

For: Duchenne Muscular Dystrophy

Emflaza (deflazacort) is a glucocorticoid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older. "HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use EMFLAZA� safely and effectively. See full prescribing information for EMFLAZA.

EMFLAZA� (deflazacort) tablets, for oral use
EMFLAZA� (deflazacort) oral suspension
Initial U.S. Approval: 2017

INDICATIONS AND USAGE
EMFLAZA is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older (1)


DOSAGE AND ADMINISTRATION
The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally (2.1)
Discontinue gradually when administered for more than a few days (2.2)
DOSAGE FORMS AND STRENGTHS
Tablets: 6 mg, 18 mg, 30 mg, and 36 mg (3)
Oral Suspension: 22.75 mg/mL (3)
CONTRAINDICATIONS
Hypersensitivity to deflazacort or any of the inactive ingredients in EMFLAZA (4)


WARNINGS AND PRECAUTIONS
Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing's syndrome, and hyperglycemia can occur; Monitor patients for these conditions with chronic use of EMFLAZA (2.2, 5.1)
Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal; Signs and symptoms of infection may be masked (5.2)
Alterations in Cardiovascular/Renal Function: Monitor for elevated blood pressure and sodium, and for decreased potassium levels (5.3)
Gastrointestinal Perforation: Increased risk in patients with certain GI disorders; Signs and symptoms may be masked (5.4)
Behavioral and Mood Disturbances: May include euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis (5.5)
Effects on Bones: Monitor for decreases in bone mineral density with chronic use of EMFLAZA (5.6)
Ophthalmic Effects: May include cataracts, infections, and glaucoma; Monitor intraocular pressure if EMFLAZA is continued for more than 6 weeks (5.7)
Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids (5.8)
Serious Skin Rashes: Discontinue at the first sign of rash, unless the rash is clearly not drug related (5.9)
ADVERSE REACTIONS
The most common adverse reactions (≥ 10% for EMFLAZA and greater than placebo) are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis (6.1)


To report SUSPECTED ADVERSE REACTIONS, contact PTC Therapeutics, Inc. at 1-866-562-4620 or [email protected] or FDA at 1-800-FDA-1088 or WWW.FDA.GOV/MEDWATCH.


DRUG INTERACTIONS
Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage of EMFLAZA (7.1)
Avoid use of moderate or strong CYP3A4 inducers with EMFLAZA, as they may reduce efficacy (7.1)
See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling.

Revised: 4/2019"

Emflaza Deflazacort 36mg 30 Tab By Marathon PharmaItem No.:Rx42998-504-03  NDC No. 42998-0504-03 42998-504-03 42998050403 4299850403  UPC/GTIN No.. 3-42998-50403-1 342998-504031 342998504031  MPN 5040
Emflaza Deflazacort 36mg
Emflaza Deflazacort 36mg 30 Tab By Marathon PharmaItem No.:Rx42998-504-03 NDC No. 42998-0504-03 42998-504-03 42998050403 4299850403 UPC/GTIN No.. 3-42998-50403-1 342998-504031 342998504031 MPN 5040

Emflaza Deflazacort 30mg 30 Tab By Marathon PharmaItem No.:Rx42998-503-03  NDC No. 42998-0503-03 42998-503-03 429985033 4299850303  UPC/GTIN No.. 3-42998-50303-4 342998-503034 342998503034  MPN 850303
Emflaza Deflazacort 30mg 30
Emflaza Deflazacort 30mg 30 Tab By Marathon PharmaItem No.:Rx42998-503-03 NDC No. 42998-0503-03 42998-503-03 429985033 4299850303 UPC/GTIN No.. 3-42998-50303-4 342998-503034 342998503034 MPN 850303

Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.
American Pharma Wholesale
Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.

Emflaza Deflazacort 6mg 100 Tab By Marathon Pharma Item No.:Rx52856-501-01 52856-501-01 NDC No.52856-501-01, 52856-502-03, 52856-503-03, 52856-504-03 UPC No.:367457190151 NDC No. 67457-0190-15 UPC/GTI
Emflaza Deflazacort 6mg 100
Emflaza Deflazacort 6mg 100 Tab By Marathon Pharma Item No.:Rx52856-501-01 52856-501-01 NDC No.52856-501-01, 52856-502-03, 52856-503-03, 52856-504-03 UPC No.:367457190151 NDC No. 67457-0190-15 UPC/GTI

Want to do Research on this Med or need a large quantity? Email Details with quantity required to:sales@AmericanPharmaWholesale.com
Buy More Save More!
Want to do Research on this Med or need a large quantity? Email Details with quantity required to:[email protected]

Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.
AmericanPharmaWholesale.com
Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.

Emflaza Deflazacort 36mg 30 Tab By Marathon PharmaItem No.:Rx42998-504-03  NDC No. 42998-0504-03 42998-504-03 42998050403 4299850403  UPC/GTIN No.. 3-42998-50403-1 342998-504031 342998504031  MPN 5040
Emflaza Deflazacort 36mg
Emflaza Deflazacort 36mg 30 Tab By Marathon PharmaItem No.:Rx42998-504-03 NDC No. 42998-0504-03 42998-504-03 42998050403 4299850403 UPC/GTIN No.. 3-42998-50403-1 342998-504031 342998504031 MPN 5040


EMFLAZA deflazacort 6MG 100 TA
"EMFLAZA (deflazacort) tablet EMFLAZA (deflazacort) suspension NDC Code(s): 42998-501-01, 42998-502-03, 42998-503-03, 42998-504-03, view more Packager: Marathon Pharmaceuticals, LLC Package Phot

Emflaza Deflazacort 30mg 30 Tab By Marathon PharmaItem No.:Rx42998-503-03  NDC No. 42998-0503-03 42998-503-03 429985033 4299850303  UPC/GTIN No.. 3-42998-50303-4 342998-503034 342998503034  MPN 850303
Emflaza Deflazacort 30mg 30
Emflaza Deflazacort 30mg 30 Tab By Marathon PharmaItem No.:Rx42998-503-03 NDC No. 42998-0503-03 42998-503-03 429985033 4299850303 UPC/GTIN No.. 3-42998-50303-4 342998-503034 342998503034 MPN 850303

Emflaza Deflazacort 18mg 30 Tab By Marathon PharmaItem No.:Rx42998-502-03  NDC No42998-0502-03 42998-502-03 42998050203 4299850203  UPC/GTIN No.. 3-42998-50203-7 342998-502037 3-42998-50203-7 MPN 8502
Emflaza Deflazacort 18mg
Emflaza Deflazacort 18mg 30 Tab By Marathon PharmaItem No.:Rx42998-502-03 NDC No42998-0502-03 42998-502-03 42998050203 4299850203 UPC/GTIN No.. 3-42998-50203-7 342998-502037 3-42998-50203-7 MPN 8502